Markets:

Overview

News

Currencies

International

Treasuries

Mindset Pharma Inc (OP:MSSTF)

N/A UNCHANGED

Last Price Updated: 3:55 PM EDT, Oct 24, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Mindset Pharma Inc

< Previous 1 2 3 4 Next >

Most, But Not All, Psychedelics Companies Have Sufficient Liquidity ↗

September 06, 2022

The Chart represents the liquidity positions of the 21 Psychedelic sector companies in the Viridian Value Tracker database.

Via Benzinga

Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

September 02, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 6.41% at $0.29

Via Benzinga

This Company Just Created 3 Brand New Psychedelics—Without The Hallucinogenic Side Effects ↗

August 31, 2022

Mindset Pharma Inc. (OTCQB: MSSTF), a company producing psychedelic and non-psychedelic drugs for mental health conditions has recently identified three additional families of highly novel,...

Via Benzinga

Intranasal Psychedelics Platform Is Here, Check Out Mindset's New Development ↗

June 30, 2022

In the process of creating optimized next-generation psychedelic medicines for neurological and psychiatric disorders, drug discovery and development company Mindset Pharma Inc.

Via Benzinga

Mindset Partners With Canadian Psychiatric Research Hospital For Preclinical Study Of Psilocybin-Derived MSP-1014 ↗

June 22, 2022

Mindset Pharma Inc.

Via Benzinga

Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill ↗

June 15, 2022

Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider.

Via Benzinga

Mindset Approved For Patent Application Involving Psilocin Derivatives For Central Nervous System Disorders ↗

June 10, 2022

Mindset Pharma Inc.

Via Benzinga

Psychedelic Medicine: The New Frontier In Healthcare, The Big Opportunity In Biopharma ↗

May 13, 2022

The story around psychedelic medicine continues to get bigger.

Via Talk Markets

Psychedelic Drug Patenting: Still Only Scratching The Surface ↗

April 26, 2022

Psychedelic drug R&D remains in its infancy, with dozens of psychedelics and several

Via Talk Markets

Revive Therapeutics, Cybin Among Top Psychedelic Movers Of Today ↗

April 08, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.54% at $0.16

Via Benzinga

Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today ↗

April 07, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.48% at $0.14

Via Benzinga

Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today ↗

April 06, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 4.78% at $19.73 LOSERS:

Via Benzinga

Psychedelic Stock Gainers And Losers From April 5, 2022 ↗

April 05, 2022

GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 1.60% at $1.27 LOSERS:

Via Benzinga

Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today ↗

April 04, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.06% at $14.18

Via Benzinga

Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗

April 01, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 5.26% at $0.86

Via Benzinga

Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗

March 31, 2022

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.38% at $0.27

Via Benzinga

Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today ↗

March 30, 2022

GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 4.22% at $0.46

Via Benzinga

Psychedelic Stock Gainers And Losers From March 29, 2022 ↗

March 29, 2022

GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 9.05% at $5.42

Via Benzinga

Mindset Pharma, Small Pharma Among Top Psychedelic Movers Of Today ↗

March 28, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 8.24% at $0.18

Via Benzinga

Psychedelic Stock Gainers And Losers From March 25, 2022 ↗

March 25, 2022

GAINERS: Allied (OTC:

Via Benzinga

Allied, Field Trip Health Among Top Psychedelic Movers Of Today ↗

March 24, 2022

GAINERS: Allied (OTC:

Via Benzinga

Five Companies Developing Second Generation Psychedelics For Mental Health ↗

March 24, 2022

Along with the psychedelic renaissance came a new type of drug: second generation psychedelics. Developed from classic psychedelics ...

Via Benzinga

Psychedelic Stock Gainers And Losers From March 23, 2022 ↗

March 23, 2022

GAINERS: Compass Pathways (NASDAQ:

Via Benzinga

Mindset Pharma, Compass Pathways Among Top Psychedelic Movers Of Today ↗

March 22, 2022

GAINERS: Mind Medicine (NASDAQ:

Via Benzinga

Field Trip Health, Mindset Pharma Among Top Psychedelic Movers Of Today ↗

March 21, 2022

GAINERS: Field Trip Health (NASDAQ:

Via Benzinga

Field Trip Health, Allied Among Top Psychedelic Movers Of Today ↗

March 18, 2022

GAINERS: Field Trip Health (NASDAQ:

Via Benzinga

Psychedelic Stock Gainers And Losers From March 16, 2022 ↗

March 16, 2022

GAINERS: Mindset Pharma (OTC:

Via Benzinga

Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today ↗

March 11, 2022

GAINERS: Allied (OTC:

Via Benzinga

Psychedelic Stock Gainers And Losers From March 10, 2022 ↗

March 10, 2022

GAINERS: Revive Therapeutics (OTC:

Via Benzinga

Psychedelic Stock Gainers And Losers From March 2, 2022 ↗

March 02, 2022

GAINERS: Mindset Pharma (OTC:

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.